Patent details

EP3580569 Title: IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY

Basic Information

Publication number:
EP3580569
PCT Application Number:
JP2018004090
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187082268
PCT Publication Number:
WO2018147291
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY
French Title of Invention:
BIOMARQUEUR IMMUNOLOGIQUE POUR PRÉDIRE L'EFFET CLINIQUE D'UNE IMMUNOTHÉRAPIE ANTICANCÉREUSE
German Title of Invention:
IMMUNOLOGISCHER BIOMARKER ZUR VORHERSAGE DER KLINISCHEN WIRKUNG EINER KREBSIMMUNTHERAPIE
SPC Number:

Dates

Filing date:
06/02/2018
Grant date:
09/03/2022
EP Publication Date:
18/12/2019
PCT Publication Date:
16/08/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/03/2022
EP B1 Publication Date:
09/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/02/2023
Expiration date:
06/02/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2022
 
 

Name:
Saitama Medical University
Address:
38, Morohongo Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan (JP)

Inventor

Name:
KAGAMU Hiroshi
Address:
Japan (JP)

Priority

1

Priority Number:
2017020685
Priority Date:
07/02/2017
Priority Country:
Japan (JP)

2

Priority Number:
2017110069
Priority Date:
02/06/2017
Priority Country:
Japan (JP)

Classification

IPC classification:
G01N 33/574;

Publication

European Patent Bulletin

Issue number:
202210
Publication date:
09/03/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages